Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Condition:   Peripheral T Cell Lymphoma Intervention:   Drug: CAR-T Therapy Sponsor:   Zhao Weili Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials